Bloomberg News interviewed the American Botanical Council's Mark Blumenthal following the publication of an FDA study on infants and consumption of herbal teas.
American Botanical Council (ABC; Austin, TX) executive director Mark Blumenthal was interviewed by Bloomberg News last week following the publication of an FDA study on infants and consumption of herbal teas.
The journal Pediatrics published a study conducted by researchers at FDA’s Center for Food Safety and Applied Nutrition, which found that 9% of 2653 mothers surveyed had given herbal teas to their infants during their first year of life. Herbal teas, including chamomile, mint, Echinacea, and other ingredients, were given to infants for health conditions like poor digestion and fussiness.
The FDA study pointed to concerns that such teas may contain contaminants or cause adverse drug reactions.
“Parents of infants and young children should understand that dietary supplements have not been evaluated by FDA to treat, cure or prevent any disease and that using them as such may not be appropriate,” said Sara Fein, a study author, in an e-mail to Bloomberg News. “Healthcare providers should recognize that infants under their care may have been given one or more of a wide variety of different dietary botanical supplements and teas.”
ABC’s Blumenthal told the Bloomberg News writer that tea supplementation in infants can be relatively safe if handled appropriately and when parents educate themselves before using products.
“Many of the herbs that [the study authors] surveyed reflect the use of these herbs by hundreds of years by mothers for colic and upset stomach,” said Blumenthal in an interview with Bloomberg News. “The majority of these products and ingredients seem to be relatively safe and mild especially when given appropriately.”
In an ABC press release, Blumenthal notes that results of the survey indicated potentially unsafe use of the teas by mothers who administered them to infants three months old or younger.
“Blumenthal said parents should consult with midwives, pediatricians, other healthcare practitioners and family members to educate themselves before administering anything other than breast milk or formula to their infants,” wrote Bloomberg News.
Driving Sustainability in Nutraceuticals: How Ingredient Brands Are Raising the Bar
April 26th 2024Health-minded consumers, especially Generation Z, value nutraceutical companies with sustainability embedded into their corporate philosophy—from product development to packaging. This article discusses how responsible companies are responding to the consumer call for greater sustainability by implementing environmentally friendly manufacturing practices that ultimately lead to waste reduction, improved supplier communications and lower supply chain risk. Those who have taken steps to demonstrate a genuine commitment to sustainability are standing out with improved outcomes for all.
The Nutritional Outlook Podcast Episode 29: 2024 Ingredients to Watch
January 31st 2024Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2024.
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.